Antibody Drug Conjugate

Antibody-drug conjugates or ADCs are a new class of highly potent biopharmaceutical drugs designed as a targeted therapy for the treatment of people with cancer. By combining the unique targeting capabilities of monoclonal antibodies with the cancer-killing ability of cytotoxic drugs, antibody-drug conjugates allow sensitive discrimination between healthy and diseased tissue. This means that, in contrast to traditional chemotherapeutic agents, antibody-drug conjugates target and attack the cancer cell so that healthy cells are less severely affected. The biochemical reaction between the antibody and the target protein (antigen) triggers a signal in the tumor cell, which then absorbs or internalizes the antibody together with the cytotoxin. A stable link between the antibody and cytotoxic (anti-cancer) agent is a crucial aspect of an ADC.

Linkers are based on chemical motifs including disulfides, hydrazones or peptides (cleavable), or thioethers (noncleavable) and control the distribution and delivery of the cytotoxic agent to the target cell. Cleavable and noncleavable types of linkers have been proven to be safe in preclinical and clinical trials.

    Related Conference of Antibody Drug Conjugate

    December 14-15, 2017

    World Immunology Congress

    Dubai, UAE
    April 19-20, 2018

    7th World Congress on Immunology

    Amsterdam, Netherlands
    May 16-17, 2018

    World Congress on Allergy and Immunotherapy

    Osaka, Japan

    July 05-07, 2018

    EuroSciCon Conference on Immunology Conference 2018

    Vienna, Austria
    July 12-13, 2018

    5th International Conference on Parasitology

    Paris, France
    August 06-07, 2018

    International Immunology Conference

    Dubai, UAE
    September 13-14, 2018

    Annual Congress on Immunology & Immunotechnology

    Zurich, Switzerland
    September 24-26, 2018

    International Conference on Hepatitis

    Amsterdam, Netherlands
    October 19-20, 2018

    10th World Congress and Expo on Immunology

    Baltimore, USA
    October 29-30, 2018

    6th International Conference on HIV/AIDS, STDs and STIs

    San Francisco, USA
    November 15-17, 2018

    Conference on Viral Infection and Immune Response

    Dubai, UAE
    November 26-27, 2018

    3rd International Conference on Autoimmunity

    Dublin, Ireland
    December 05-06-2018

    Conference on Biostatistics and Informatics

    Dubai, UAE
    December 13-14 , 2018

    Allergy and Clinical Immunology

    Abudhabi

    Antibody Drug Conjugate Conference Speakers